169 related articles for article (PubMed ID: 11571235)
21. Sudden death after myocardial infarction--who needs prophylaxis, and when?
Buxton AE
N Engl J Med; 2005 Jun; 352(25):2638-40. PubMed ID: 15972871
[No Abstract] [Full Text] [Related]
22. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
23. Age and effectiveness of prophylactic implantable cardioverter-defibrillators.
Barsheshet A; Goldenberg I
Ann Intern Med; 2011 Apr; 154(7):505; author reply 505-6. PubMed ID: 21464356
[No Abstract] [Full Text] [Related]
24. Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry.
Hiremath S; Punnam SR; Brar SS; Goyal SK; Gardiner JC; Shah AJ; Thakur RK
Am J Nephrol; 2010; 32(4):305-10. PubMed ID: 20714135
[TBL] [Abstract][Full Text] [Related]
25. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
Gersh B
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):16-7. PubMed ID: 16265252
[No Abstract] [Full Text] [Related]
26. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
Talajic M; Mitchell LB; Hadjis T
Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
[No Abstract] [Full Text] [Related]
27. Age and effectiveness of implantable cardioverter-defibrillators.
Braunschweig F; Wedel H
Ann Intern Med; 2011 Aug; 155(3):201; author reply 201-2. PubMed ID: 21810715
[No Abstract] [Full Text] [Related]
28. The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits.
Jolly S; Dorian P; Alter DA
J Eval Clin Pract; 2006 Apr; 12(2):190-5. PubMed ID: 16579828
[TBL] [Abstract][Full Text] [Related]
29. Ethical issues with implantable defibrillators.
Veenhuyzen GD; Simpson CS
Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
[No Abstract] [Full Text] [Related]
30. Ethical issues with implantable defibrillators.
Brennan FJ
Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
[No Abstract] [Full Text] [Related]
31. [Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology].
Aliot E; Chauvin M; Daubert JC; Frank R; Jondeau G; Leclercq JF; Le Heuzey JY;
Arch Mal Coeur Vaiss; 2006 Feb; 99(2):141-54. PubMed ID: 16555698
[No Abstract] [Full Text] [Related]
32. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
[TBL] [Abstract][Full Text] [Related]
33. Comments on ethical issues with implantable defibrillators by F. James Brennan.
Rahmoeller G
Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
[No Abstract] [Full Text] [Related]
34. [Programmed left ventricular stimulation in non-sustained ventricular arrhythmias].
Kossaify A; Belin A; Grollier G; Potier B; Citerne O; Hurpe JM; Scanu P
Arch Mal Coeur Vaiss; 2001 Dec; 94(12):1367-72. PubMed ID: 11828921
[TBL] [Abstract][Full Text] [Related]
35. Implantable cardioverter-defibrillator and mortality in dialysis patients.
Saravanan P; Davidson NC
Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
[No Abstract] [Full Text] [Related]
36. Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?
Ray IB; Reddy VY
Int J Cardiol; 2005 Jan; 98(1):15-20. PubMed ID: 15676160
[TBL] [Abstract][Full Text] [Related]
37. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
Disertori M; El-Sherif N
Ital Heart J; 2004 Sep; 5(9):643-7. PubMed ID: 15568590
[No Abstract] [Full Text] [Related]
38. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
Goldberger JJ; Passman R
J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
[TBL] [Abstract][Full Text] [Related]
40. [ICD-implantation--for which patients is its value for primary prevention secure?].
Fiek M; Reithmann C; Steinbeck G
Dtsch Med Wochenschr; 2006 Sep; 131(39):2165-8. PubMed ID: 16991035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
